Short	O
-	O
Term	O
Influence	O
of	O
Radiofrequency	B:C0850292
Ablation	I:C0850292
on	O
N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B-type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
MR	B:C2975328
-	I:C2975328
proANP	I:C2975328
,	O
Copeptin	B:C3489439
,	O
and	O
midregional	B:C3493807
portion	I:C3493807
of	I:C3493807
proadrenomedullin	I:C3493807
in	O
Patients	O
With	O
Atrial	B:C0004238
Fibrillation	I:C0004238
:	O
Data	O
From	O
the	O
Observational	B:C1518527
SMURF	I:C1518527
Study	I:C1518527
.	O

There	O
is	O
limited	O
knowledge	O
on	O
the	O
short	O
-	O
term	O
influence	O
of	O
radiofrequency	B:C0850292
ablation	I:C0850292
(	O
radiofrequency	B:C0850292
ablation	I:C0850292
)	O
of	O
atrial	B:C0004238
fibrillation	I:C0004238
(	O
atrial	B:C0004238
fibrillation	I:C0004238
)	O
on	O
2	O
cardiac	B:C2735102
biomarkers	I:C2735102
;	O
the	O
N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
(	O
N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
)	O
and	O
the	O
midregional	B:C2975328
fragment	I:C2975328
of	I:C2975328
the	I:C2975328
N	I:C2975328
-	I:C2975328
terminal	I:C2975328
of	I:C2975328
pro-ANP	I:C2975328
(	O
MR	B:C2975328
-	I:C2975328
proANP	I:C2975328
)	O
and	O
2	O
extracardiac	B:C2735102
biomarkers	I:C2735102
;	O
the	O
c-terminal	B:C0056279
provasopressin	I:C0056279
(	O
copeptin	B:C0056279
)	O
and	O
the	O
midregional	B:C3493807
portion	I:C3493807
of	I:C3493807
proadrenomedullin	I:C3493807
(	O
midregional	B:C3493807
portion	I:C3493807
of	I:C3493807
proadrenomedullin	I:C3493807
)	O
.	O

There	O
are	O
also	O
limited	O
data	O
concerning	O
cardiac	B:C0018787
production	O
of	O
the	O
latter	O
two	O
.	O

We	O
studied	O
192	O
consecutive	O
patients	O
eligible	O
for	O
radiofrequency	B:C0850292
ablation	I:C0850292
of	O
atrial	B:C0004238
fibrillation	I:C0004238
referred	O
to	O
the	O
University	B:C0020028
Hospital	I:C0020028
,	O
Link√∂ping	B:C0038995
,	I:C0038995
Sweden	I:C0038995
.	O

N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B	I:C0754710
-type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
,	O
MR	B:C2975328
-	I:C2975328
proANP	I:C2975328
,	O
copeptin	B:C3489439
,	O
and	O
midregional	B:C3493807
portion	I:C3493807
of	I:C3493807
proadrenomedullin	I:C3493807
levels	O
were	O
measured	O
in	O
peripheral	B:C0229664
blood	I:C0229664
,	O
the	O
coronary	B:C0456944
sinus	I:C0456944
(	O
coronary	B:C0456944
sinus	I:C0456944
)	O
,	O
and	O
the	O
left	B:C0225860
atrium	I:C0225860
before	O
ablation	B:C0547070
,	O
and	O
in	O
peripheral	B:C0229664
blood	I:C0229664
immediately	O
and	O
the	O
day	O
after	O
radiofrequency	B:C0850292
ablation	I:C0850292
.	O

The	O
level	O
of	O
N	B:C0754710
-	I:C0754710
terminal	I:C0754710
pro-B	I:C0754710
-	I:C0754710
type	I:C0754710
natriuretic	I:C0754710
peptide	I:C0754710
decreased	O
the	O
day	O
after	O
radiofrequency	B:C0850292
ablation	I:C0850292
in	O
participants	B:C0679646
in	O
atrial	B:C0004238
fibrillation	I:C0004238
at	O
the	O
time	O
of	O
radiofrequency	B:C0850292
ablation	I:C0850292
,	O
compared	O
to	O
the	O
participants	B:C0679646
in	O
sinus	B:C0232201
rhythm	I:C0232201
who	O
showed	O
a	O
slight	O
increase	O
(	O
P<	O
0.001	O
)	O
.	O

Furthermore	O
,	O
regardless	O
of	O
the	O
actual	B:C0232187
rhythm	I:C0232187
,	O
the	O
level	O
of	O
MR	B:C2975328
-	I:C2975328
proANP	I:C2975328
showed	O
an	O
increase	O
immediately	O
after	O
radiofrequency	B:C0850292
ablation	I:C0850292
(	O
P<	O
0.001	O
)	O
,	O
followed	O
by	O
a	O
decrease	O
the	O
day	O
after	O
ablation	B:C0547070
(	O
P<	O
0.001	O
)	O
.	O

Copeptin	B:C4284455
level	I:C4284455
showed	O
a	O
6	O
-	O
fold	O
increase	O
immediately	O
after	O
radiofrequency	B:C0850292
ablation	I:C0850292
compared	O
to	O
baseline	O
(	O
P<	O
0.001	O
)	O
,	O
whereas	O
midregional	B:C3493807
portion	I:C3493807
of	I:C3493807
proadrenomedullin	I:C3493807
level	O
increased	O
the	O
day	O
after	O
radiofrequency	B:C0850292
ablation	I:C0850292
(	O
P<	O
0.001	O
)	O
.	O

Levels	O
of	O
copeptin	B:C0056279
and	O
midregional	B:C3493807
portion	I:C3493807
of	I:C3493807
proadrenomedullin	I:C3493807
were	O
not	O
higher	O
in	O
the	O
coronary	B:C0456944
sinus	I:C0456944
compared	O
to	O
peripheral	B:C0229664
blood	I:C0229664
.	O

radiofrequency	B:C0850292
ablation	I:C0850292
of	O
atrial	B:C0004238
fibrillation	I:C0004238
is	O
a	O
strong	O
stimulus	O
with	O
a	O
significant	O
and	O
direct	O
impact	O
on	O
different	O
neurohormonal	B:C0597049
systems	I:C0597049
.	O

We	O
found	O
no	B:C0311392
sign	I:C0311392
of	O
a	O
cardiac	B:C0018787
release	O
of	O
midregional	B:C3493807
portion	I:C3493807
of	I:C3493807
proadrenomedullin	I:C3493807
or	O
copeptin	B:C0056279
.	O

